MyEClinic
MyEClinic
Health Dictionary Find a Doctor

VTD-PACE regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Velcade-thalidomide-dexamethasone-Platinum-Adriamycin-cyclophosphamide-etoposide regimen

Overview

VTD-PACE regimen refers to a regimen consisting of bortezomib (Velcade), thalidomide, dexamethasone, Platinum (cisplatin), Adriamycin (doxorubicin), cyclophosphamide, and etoposide used to treat multiple myeloma.[1]

Regimen

VBortezomib (Velcade)

TThalidomide

DDexamethasone

PPlatinum (cisplatin)

AAdriamycin (doxorubicin)

CCyclophosphamide

EEtoposide

Indications

References

  1. ↑ 1.0 1.1 Barlogie B, Anaissie E, van Rhee F, Haessler J, Hollmig K, Pineda-Roman M; et al. (2007). “Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3”. Br J Haematol. 138 (2): 176–85. doi:10.1111/j.1365-2141.2007.06639.x. PMID 17593024.

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH